Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey

Sarlós Patrícia and Bikar Alexander and Borbásné Farkas Kornélia and Resál Tamás and Szepes Zoltán and Farkas Klaudia and Nagy Ferenc and Vincze Áron and Miheller Pál and Molnár Tamás: Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease: results of a multicenter survey.
EXPERT OPINION ON BIOLOGICAL THERAPY, 23 (8). pp. 827-832. ISSN 1471-2598 (2023)

[thumbnail of 33826696_megjelent.pdf] Text
33826696_megjelent.pdf - Published Version

Download (263kB)
[thumbnail of 33826696_elfogadott.pdf] Text
33826696_elfogadott.pdf - Accepted Version
Closed access: Repository staff only amíg 2024. May 09..

Download (263kB) | Request a copy
Item Type: Journal Article
Journal or Publication Title: EXPERT OPINION ON BIOLOGICAL THERAPY
Date: 2023
Volume: 23
Number: 8
Page Range: pp. 827-832
ISSN: 1471-2598
Faculty/Unit: Albert Szent-Györgyi Medical School
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 33826696
DOI azonosító: https://doi.org/10.1080/14712598.2023.2211204
Date Deposited: 2023. Jul. 11. 12:21
Last Modified: 2023. Oct. 02. 10:51
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/27844

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year